MSD UK customer services
01992 452094
(During public holidays please contact our UK switchboard on 01992 467272).
Emergency patient supply order form
Please click here to download an emergency patient supply order form (for use by UK healthcare professionals only).
Supply Status
|
Product Description
|
Supply Status
|
Estimated Resupply Date
|
|
ASMANEX®
Twisthaler® 200 micrograms Inhalation Powder 30 Dose
|
Out of Stock
|
March 2020
|
|
ASMANEX®
Twisthaler® 200 micrograms Inhalation Powder 60 Dose
|
Limited Stock
|
March 2020
|
|
ASMANEX®
Twisthaler® 400 micrograms Inhalation Powder 30 Dose
|
Limited Stock
|
March 2020
|
|
EMEND®
125 mg powder for oral suspension
|
Out of Stock
|
Mid March 2020
|
|
NOXAFIL®
100 mg gastro-resistant 8 X 12 TAB
|
Limited Stock
|
Intermittent Supply until Q1 2020
|
|
PROPECIA®
1 mg Film-Coated Tablets 6 X 14 TAB
|
Out of Stock
|
Late February 2020
|
|
ZOELY®▼
2.5 mg/1.5 mg film-coated Tablets
|
Out of Stock
|
Q1 2022
|
Notifications
During the month of June 2019 onwards pembrolizumab will cease to be available in the 50 mg vial as lyophilised powder (50 mg powder for concentrate for solution for infusion). It will be supplied by MSD in the UK exclusively in the form of 100 mg vial (25 mg/mL concentrate for solution for infusion).
As this date is determined by the level of the demand for this presentation a precise date cannot be provided. As such we recommend that all Trusts take appropriate steps to ensure they are able to use the 100 mg presentation.
Discontinuations
- Product Description
- COZAAR® 2.5 mg/ml powder and solvent for oral suspension
This page is intended for use by UK healthcare professionals only. Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck & Co., Inc., Kenilworth, NJ, USA, its subsidiaries or affiliates, except as noted.
Job code: GB-NON-02220Date of preparation: January 2020